A more liberal application of this therapeutic modality resulted in the observation that bone marrow transplantation (BMT) resulted in a lower relapse rate, independent of the cytotoxic therapy establishing the entity of the Graft Versus Leukemia (GVL) effect. In the first half of the century, radiation was observed to have profound suppressive effects on the immune system3. In addition to the incompatibility of the major and minor histocompatibility antigens, hematopoietic histocompatibility antigens (Hh), which are present on bone marrow cells, are also involved in the rejection of bone marrow transplants43.
MATERIALS AND METHODS
The cells were then washed and incubated for an additional 20 min with 0.1 ml of different dilutions of serum from non-immunized and immunized mice. B cells were then collected by pipetting into a tube and washed twice with RPMI.
CHAPTER4
MECHANISMS UNDERLYING TRANSPLANTATION TOLERANCE IN MIXED BONE MARROW CHIMERAS IN A SEMIALLOGENEIC
Bone marrow cells were harvested by flushing the shafts of the sacrificed donor animals with a solution of RPMI with antibiotics and 1% heparin. The cells were reconstituted to the relevant concentration so that 0.25 ml was injected into the tail vein of the recipient, with the appropriate number of cells. Vp6 cells were evaluated in the CD4 window (Caltag laboratory, San Francisco) with Vp6 mAb (Pharmingen, Antwerp, Belgium) and percentages were estimated in the peripheral blood lymphocytes, thymus, spleen lymphocytes and lymph node lymphocytes.
The cells were counted and prepared to a concentration of 5 x 10 6 cells/ml in RPMI with 10% FCS and 2ME. Cell counts were determined and the cells were reconstituted to give a concentration of 2.5 x 10 6 cells/ml in RPMI with 10% FCS and 2ME. These cells were irradiated with 1500 Rads and were added to the MLC to determine their influence on it.
Vp6 cells: These cells were isolated from single cell suspensions from the thymus of chimeric AKR mice using magnetic beads to isolate the cells and then adjust them to a concentration of 2.5 x 10 cells/ml. The cells were plated in 96-well flat-bottom plates; In the experiments, 5 x 105 responder cells and 5 x 105 stimulator cells were added to the wells.
C3H CELLS
Evaluation of the influence of the chimeric cells on the MLC of naive donor and recipient splenocytes. However, the addition of cells of donor or recipient origin from the TBI chimeras resulted in a significant reduction in response. To determine the significance of the Vp6 cells expanded in the TBI chimeras, single positive (CD4) Vp6 cells were added to the naïve response.
These cells resulted in a significant suppression of the response, regardless of whether the responding cells were of donor or recipient origin. However, in the TBI mice of C3H origin reconstituted into mixed chimeras with AKR/J bone marrow, all mice succumbed to tumor inoculation by 22 days (fig. 5). In the co-transfer experiments, 40 x 106 cells of naïve donor origin were injected into the lateral tail veins of lethally irradiated recipient mice.
In the TBI cotransfer groups, both the tolerant donor cells and the tolerant recipient cells provided protection against the onset of fatal GVHD. This was most likely due to the suppressive nature of these cells as evidenced by the in vitro experiments.
Survival Functions
In contrast, cells of recipient origin unexpectedly prevented the onset of GVHD, but the mechanism underlying this protection is not readily apparent in this study, and this protection persisted when chimeric tolerant cells from TLI chimeras were co-injected (fig 7).
DAYS
I STRAIN
The mechanism by which these different strategies emerge is not predictable and is currently assumed to be determined by BMT quality and MHC disparity. This is based on the results of co-transfer experiments where the injection of recipient cells from stable chimeras of TU origin protected against the occurrence of GVHD. In the TBI group, transplant tolerance could be achieved by manipulation of donor bone marrow with TCD.
Whether this is a consequence of the conditioning regimen or the quality of the bone marrow transplant has yet to be determined. The precise magnitude of this is further substantiated in the response of the chimeric animal to the donor (allogeneic) tumor. The conclusions that can be drawn from this study are that transplant tolerance is influenced by various factors, the most important of which appear to be the quality of BMT and the conditioning used to prepare the recipient.
Of greater importance is also the risk of susceptibility to donor diseases, which may be of greater risk to the recipient as a result of the depression in immune competence. GRAFT VERSUS LEUKEMIA EFFECT (GVL) - EVALUATION OF THE MECHANISMS INDEPENDENT OF GRAFT VERSUS HOST.
THE GRAFT VERSUS LEUKAEMIA EFFECT (GVL) - EVALUATION OF THE MECHANISMS INDEPENDENT OF GRAFT VERSUS HOST
DISEASE (GVHD) WITH DIFFERENT MECHANISMS OF TRANSPLANTATION TOLERANCE
Stimulator cells: Single cell suspensions were prepared from the spleen(s) of the mice as described above. After incubation, cells were washed twice with RPMI to remove excess unbound antibodies and cells were then incubated with low-toxicity rabbit complement in a 37°C water bath for 45 minutes. Vf36 cells: These cells were isolated from single cell suspensions from the thymus of chimeric AKR mice using magnetic beads to isolate the cells and then adjust them to a concentration of 2.5 x 10 cells/ml.
Then, 10:1 of [H3] thymidine was added to each well and cells were incubated for an additional 16 h, after which cells were harvested and radioactivity was measured. The concentration of antibody required was determined by titration against a known concentration of cells. Depletion was performed using magnetic beads (MACS) and cells used in co-transfection experiments were eluted by negative selection to prevent in vitro activation.
Two days later, 106 BW 5147.3 tumor cells were injected into the lateral tail vein of the mice. Five animals from each group reconstituted with semiallogeneic BMT were sacrificed and the percentage composition of and the ratios of the CD4:CDS were determined in both the peripheral blood and the spleen.
EARLY TUMOUR INNOCULATION INTO AKR MICE
Delayed tumor inoculation allowed the possibility to confirm that the animals were mixed chimeras and this was confirmed in a FACS analysis of peripheral blood using Thy 1.1 and Thy 1.2 antibodies coupled to PE and FITC respectively. All animals reconstituted with semiallogeneic BM were found to be mixed chimeras and their respective percentages are reflected below in Table 1. As expected, the outcome in the respective groups of mice mirrored those in the early tumor inoculation group with the semiallogeneic group that survived. for a significantly longer time than the reconstituted syngeneic group.
DELAYED TUMOUR INNOCULATI ON
SURVIVAL IN DAYS
TBI SYNG BMT
TLI SYNG BMT
TBI ALLO TCD BMT
TCD BMT
The cotransfer experiments were designed to attempt to establish the cell types responsible for influencing the GVL effect. As expected, the group denied allogeneic splenocytes succumbed to the tumor engraftment the fastest. Unexpectedly, all mice reconstituted with the splenocytes survived significantly longer than the group without allogeneic splenocytes.
However, the necessity of T cells to support a GVL effect can be inferred from the results as the group given splenocytes without CD4 and COB cells fared worse than the groups given mature T cells ( Fig 3).
COTRANSFER OF TOLERANT SPLENOCYTES AND TUMOUR INNOCULATION
Survival Functions
STRAIN
Bone marrow transplantation is now an essential and important therapy in the treatment of hematological malignancies. Importantly, the mechanisms that maintain transplant tolerance play a significant role in the response that is achieved. In mice conditioned with TBI, the GVL effect is significantly weaker than mice conditioned with TLI.
The cotransfer experiments performed testify to the role of the T cells in playing a role in the GVL effect. However, this effect is present even in the absence of T cells, but is best in mature splenocytes that have not been manipulated. This suggests that the GVL effect in vivo is likely mediated in association with a large number of cells playing either a direct role or a secondary role.
The conclusions of this study are that allogeneic BMT induces a GVL effect and can be achieved without the appearance of GVHD. However, the response is influenced by both the conditioning regimen and the quality of BMT.
PRESENCE OF INTRINSIC B LYMPHOCYTE TOLERANCE IN MIXED
BUT NOT IN COMPLETE SEMIALLOGENEIC BONE MARROW CHIMERAS 1
SUMMARY
In the current study, the mechanisms of tolerance that maintain chimerism and determine the behavior of chimeric animals against GVL and rejection reactions were investigated. In TBI-induced mixed chimeric animals, tolerance was not based on deletion mechanisms. On the contrary, there is an expansion of Vp6 positive recipient cells that recognize mlsa antibodies on the donor.
Furthermore, these cells behave as suppressor cells in donor versus recipient and recipient versus donor reactions and this was demonstrated in both in vivo and in vitro experiments. In contrast, mixed chimeras that have been conditioned with TLI develop a tolerance based primarily on clonal deletion, in the absence of suppressor cells. Mechanisms of transplant tolerance will be different depending on the type of conditioning regimen used as well as the GVL effect.
This suggested that intrinsic B-lymphocyte tolerance to host antigens had occurred in MC but not in MC. These results show that intrinsic B-lymphocyte tolerance can be achieved after transplantation and that this depends on the presence of lymphohematopoietic cells expressing the tolerogens.
GENERAL PERSPECTIVES AND OPINION
It is hoped that the advent of newer immunosuppressive agents will allow more predictable engraftment that eliminates GVHD and, importantly, will support transplant tolerance that will allow superior immunocompetition rather than risking susceptibility to the recipient.
Effect of selective T cell depletion in host and/or donor bone marrow on lymphopoietic repopulation, tolerance and graft-versus-host disease in mixed allogeneic chimeras (B 10 + B B 10). Contribution of CD4+ and CD8+ T cells to graft-versus-host disease and graft-versus-leukemia reactivity after. Characterization of target injury of acute graft-versus-host disease in mice directed at multiple minor histocompatibility antigens elicited by CD4+ or CD8+ effector cells.
Variable capacity of L3T4+ T cells to induce lethal graft-versus-host disease across minor histocompatibility barriers in mice. Non-mitogenic anti CD3 F(ab)2 fragments inhibit lethal murine graft-versus-host disease induced through the major histocompatibility barrier. CTLA4: B7/BB1 interaction with CTLA4-lg reduces lethal murine graft-versus-host disease across the major histocompatibility barrier in mice.
Mechanism of IL-2-mediated protection against graft-versus-host disease mortality: early depletion of donor T cell subsets and expression of the CD3+ CD4-CDa- cell population. Macrophage preparation and lipopolysaccharide induced tumor necrosis factor alpha release during graft-versus-host disease.